InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,814.32
(
0.59%
)
US TECH 100
19,745.20
(
0.21%
)
Dow Jones
42,829.63
(
0.88%
)
Brent Oil
78.77
(
-0.37%
)
Bitcoin
62,850.72
(
4.28%
)
Post# of 253343
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120559
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 117927

Friday, 04/08/2011 2:59:54 PM

Friday, April 08, 2011 2:59:54 PM

Post# of 253343
This entire thread, while of interest intellectually, is moot from an investment standpoint, IMO. Sequential dosing of the components of an all-oral HCV cocktail is done in phase-2 to assess safety, not to enhance efficacy. In phase-3 and in actual clinical practice, these drugs will almost certainly be dosed in unison.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up